Clinical Trial Update: Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial reports results for dasatinib in patients with accelerated-phase chronic myeloid leukemia, with the study completed and results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Myelogenous Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2010-03-02